Cas:29964-84-9 8-Methylnonyl methacrylate manufacturer & supplier

Chemical Name:8-Methylnonyl methacrylate

CAS.NO:29964-84-9

Synonyms:Isodecyl2-methyl-2-propenoate;MFCD00053728;8-methylnonyl 2-methylprop-2-enoate;8-Methylnonyl methacrylate;EINECS 249-978-2;Methacrylic acid 8-methylnonyl ester;Isodecylmethacrylat;2-Propenoic acid, 2-methyl-, 8-methylnonyl ester;ageflexfm-10;Methacrylicacid,isodecylester;ISODECYL METHACRYLATE;2-methyl-2-propenoicaciisodecylester;Isodecyl2-methylpropenoate

Molecular Formula:C₁₄H₂₆O₂

Molecular Weight:226.355

HS Code:

Physical and Chemical Properties:

Melting point:-22ºC

Boiling point:283.9±9.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.441

PSA:26.30000

Exact Mass:226.193283

LogP:5.94

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3082 9 / PGIII

Packing Group:

Contact us for information like Isodecyl2-methyl-2-propenoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Isodecyl2-methylpropenoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ISODECYL METHACRYLATE Use and application,2-methyl-2-propenoicaciisodecylester technical grade,usp/ep/jp grade.

Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 8-Methylnonyl methacrylate manufacturer ICIG has agreed to offer employment to the unit��s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland. 8-Methylnonyl methacrylate supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 8-Methylnonyl methacrylate vendor ICIG has agreed to offer employment to the unit��s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland. 8-Methylnonyl methacrylate factory ICIG has agreed to offer employment to the unit��s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.